Accelerate to discover
Related topics
Micro-CT: Fancy gadget or indispensable technology towards quantification of lung diseases?
Jul 29, 2020
Technology allowing evaluation of live animals repeatedly is indispensable to gain better insight into the dynamics of...
Breakthrough discoveries from shear flow assays for Platelet biology and vascular studies
Jul 17, 2020
After a short introduction on the physio-pathological roles of platelets and the importance of their cell adhesion...
Hybrid PET/MR enables exploration of new science
Jul 14, 2020
Watch the recorded webinar on PET/MR, driven by Peter Caravan at MGH for the application part, during which the launch...
IncuCyte webinar: Advances in 3D cell models for cancer biology
Jul 1, 2020
Get answers to your questions on 3D spheroid-based drug discovery, organoid research and working with advanced cell...
MicroCT Applications in Lung research and Immunology
Jun 22, 2020
The ability to monitore and quantitate lung disease in real time is an advantage to using small animal microCT. Also,...
Saphyr identifies all variants detected by the standard of care in cytogenetics
Jun 1, 2020
Cancer genomics consortium members demonstrate 100% concordance between Bionano Genomics optical mapping technology and...
Webinar recording: Isolating ultra-high molecular weight (UHMW) DNA for genome analysis
May 12, 2020
Watch the webinar from Bionano Genomics and learn the tips and tricks for isolating high quality UHMW DNA - right from...
Isoflux webinar: Accurate liquid biopsy approach reveals mutations in lung cancer patients
Apr 29, 2020
Liquid biopsies aim to identify clinically actionable information from cell-free DNA (cfDNA) and circulating tumor...
Oct 13, 2016
Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).
Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
